• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Pfizer bags USFDA approval for Besponsa biospectrumasia
    August 22, 2017
    The regulatory agency approved the Besponsa, drug fro the treatment of leukemia, under Priority Review and Breakthrough Therapy status
  • EC approves Pfizer’s acute lymphoblastic leukemia treatment Besponsa pharmaceutical-technology
    July 05, 2017
    The European Commission (EC) has approved Pfizer’s Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in the European Union (EU).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service